-Enhance Conjugation of Target Molecules
-Enhance Binding Geometry
-Eliminate Aggregation
-Eliminate Non-Specific Binding
-Optimize Signal to Noise

For more information on this exciting New product Click Here

Quanta BioDesign is a research and manufacturing company committed to the development of a full range of discrete polyethylene glycol (dPEG^®) PEGylation reagents for applications in diagnostics, therapeutics, peptide synthesis, oligonucleotide synthesis, and nanotechnology.

Quanta BioDesign's vision incorporates a dedicated commitment to producing the most useful compounds for your current and future applications and needs using synthetic and process technology that allows the the most economic incoporation of these product into your application.